[ad_1]
SINGAPORE – Health authorities have advised against the use of two flu vaccines, SKYCellflu Quadrivalent and VaxigripTetra, after people died after receiving them in South Korea.
There have been no deaths associated with influenza vaccination here, noted the Ministry of Health (MOH) and the Health Sciences Authority (HSA) on Sunday (October 25), adding: “This is a measure of Caution Following Deaths Reported After Influenza Vaccination In Korea. ”
Information from South Korean authorities indicated that seven brands of influenza vaccine had been administered to people who died in South Korea.
Two of the seven brands are available in Singapore: SKYCellflu Quadrivalent is manufactured by SK Bioscience and distributed here by AJ Biologics; VaxigripTetra is produced by Sanofi Pasteur and distributed locally by Sanofi Aventis.
The HSA is evaluating the implications of the deaths reported in South Korea and the Health Ministry has told healthcare providers and doctors to temporarily stop using the two vaccines.
But the other two vaccines that have been brought to Singapore for the flu season can still be used, they added.
Like any medicine, vaccines can cause side effects, such as pain and redness at the injection site, fever, headaches, muscle aches, fatigue, and nausea.
“These side effects are generally mild and resolve on their own. On rare occasions, a person may experience a high fever or severe allergic reactions (such as difficulty breathing, wheezing, and swelling around the eyes) and immediate medical attention should be sought. , He said. agencies.
They added that the vaccines approved for use here have been evaluated by the HSA to ensure they meet required international standards for quality, safety, and efficacy.
The HSA monitors vaccine safety through a monitoring system that relies on the network of local health professionals and international regulatory partners to detect adverse events suspected of being associated with the drugs.
[ad_2]
